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Thalamic pathology and memory loss in early
Alzheimer’s disease: moving the focus from the
medial temporal lobe to Papez circuit
John P. Aggleton,1 Agathe Pralus,2 Andrew J. D. Nelson1 and Michael Hornberger3
It is widely assumed that incipient protein pathology in the medial temporal lobe instigates the loss of episodic memory in
Alzheimer’s disease, one of the earliest cognitive deﬁcits in this type of dementia. Within this region, the hippocampus is seen
as the most vital for episodic memory. Consequently, research into the causes of memory loss in Alzheimer’s disease continues to
centre on hippocampal dysfunction and how disease-modifying therapies in this region can potentially alleviate memory sympto-
mology. The present review questions this entrenched notion by bringing together ﬁndings from post-mortem studies, non-invasive
imaging (including studies of presymptomatic, at-risk cases) and genetically modiﬁed animal models. The combined evidence
indicates that the loss of episodic memory in early Alzheimer’s disease reﬂects much wider neurodegeneration in an extended
mnemonic system (Papez circuit), which critically involves the limbic thalamus. Within this system, the anterior thalamic nuclei are
prominent, both for their vital contributions to episodic memory and for how these same nuclei appear vulnerable in prodromal
Alzheimer’s disease. As thalamic abnormalities occur in some of the earliest stages of the disease, the idea that such changes are
merely secondary to medial temporal lobe dysfunctions is challenged. This alternate view is further strengthened by the inter-
dependent relationship between the anterior thalamic nuclei and retrosplenial cortex, given how dysfunctions in the latter cortical
area provide some of the earliest in vivo imaging evidence of prodromal Alzheimer’s disease. Appreciating the importance of the
anterior thalamic nuclei for memory and attention provides a more balanced understanding of Alzheimer’s disease. Furthermore,
this refocus on the limbic thalamus, as well as the rest of Papez circuit, would have signiﬁcant implications for the diagnostics,
modelling, and experimental treatment of cognitive symptoms in Alzheimer’s disease.
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Introduction
Alzheimer’s disease is the most prevalent form of dementia,
currently affecting 47 million people worldwide, with the
number of patients with Alzheimer’s disease projected to
triple over the next 30 years (WHO, 2012). There is an
urgent need for disease-modifying therapies to alleviate or,
ideally, halt Alzheimer’s disease symptoms. While therapies
are currently in development, the effectiveness of this en-
deavour is critically dependent on sensitive outcome
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measures that target regional speciﬁc dysfunctions in
Alzheimer’s disease. Most outcome measures concern the
ability to remediate the well-established pathological
changes seen in the medial temporal lobe in Alzheimer’s
disease and its prodromal forms (Hyman et al., 1990;
Braak et al., 1997; Craig et al., 2011). This attention on
the medial temporal lobe is reinforced by the long-standing
assumption that the hippocampus, in concert with its para-
hippocampal connections, is the pre-eminent brain region
supporting episodic memory (Spiers et al., 2001; Squire et
al., 2004; Diana et al., 2007), the category of memory that
concerns the day-to-day events that make up our lives. In
this way, neuropathological ﬁndings from patients with
Alzheimer’s disease have been integrated with its leading
cognitive failure (episodic memory loss), further adding to
the focus on the medial temporal lobe. Consequently, it has
been argued that an amnesic syndrome of the hippocampal
type is an essential core feature for the diagnosis of typical
Alzheimer’s disease (Sarazin et al., 2007). Indeed,
Alzheimer’s disease has been seen by some as fundamen-
tally a hippocampal dementia (Craig et al., 2011). In prac-
tice, Alzheimer’s disease can also present with prominent
language (e.g. logopenic aphasia), visual (e.g. posterior cor-
tical atrophy) or motor (e.g. corticobasal degeneration)
symptoms, reﬂecting different combinations of pathologies
that extend beyond the hippocampus (Hof et al., 1997;
Caine and Hodges, 2001; Lambon Ralph et al., 2003;
Dubois et al., 2010).
While the continuing focus on the medial temporal lobe
for memory loss is understandable, it comes at a potential
price. There remains the possibility that pathologies in
other areas play a key role in disrupting memory, starting
from the earliest stages of the disease. Two candidate areas
are: (i) the posterior cingulate region, which includes the
retrosplenial cortex (see ‘Anterior thalamic–retrosplenial
cortex interactions’ section); and (ii) the limbic thalamus.
The principal nuclei of the limbic thalamus consist of the
anterior thalamic nuclei, the lateral dorsal nucleus, and the
medial dorsal nucleus (Taber et al., 2004). Both the pos-
terior cingulate region and the anterior thalamic nuclei are
key components of Papez circuit (Fig. 1), so that both have
dense, direct hippocampal connections, which principally
involve the subiculum and presubiculum (Aggleton et al.,
1986; Vogt et al., 1987; Kobayashi and Amaral, 2003,
2007; Aggleton, 2012).
There has been a steady growth of interest in the poten-
tial importance of the posterior cingulate region during the
initial development of Alzheimer’s disease (see below). As
noted, its apparent importance could reﬂect the many
direct, reciprocal connections between the posterior cingu-
late cortices and the hippocampal formation (Vogt et al.,
1987; Kobayashi and Amaral, 2003, 2007; Aggleton et al.,
2014). Alternatively, it could reﬂect how the posterior cin-
gulate region is part of Papez circuit (Fig. 1), where it forms
a node between the anterior thalamic nuclei and the hippo-
campal formation (Vann et al., 2009). To distinguish these
accounts it is necessary to examine the status of speciﬁc
thalamic nuclei during the development of Alzheimer’s dis-
ease. If it appears that anterior thalamic dysfunction does
not contribute to the early stages of Alzheimer’s disease,
then it can be assumed that it is the direct hippocampal–
posterior cingulate connections that suffer the key, initial
dysfunctions. If, however, anterior thalamic dysfunctions
are present from the earliest stages of the disorder, this
Figure 1 Illustrations showing the location of the anterior thalamic nuclei within Papez circuit and the limbic system.
(A) Schematic drawing of Papez circuit (in black). (B) Schematic diagram of the key connections between the anterior thalamic nuclei and
laterodorsal thalamic nucleus with sites implicated in Alzheimer’s disease. ATN = anterior thalamic nuclei; HPC/SUB = hippocampal formation,
including subiculum; LD = laterodorsal thalamic nucleus; MMB = mammillary bodies; MTT = mammillothalamic tract;
PARAHPC = parahippocampal region; PFC = prefrontal cortex; RSC = retrosplenial cortex.
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calls for a systems analysis that involves the wider (Papez)
network. Unfortunately, the thalamus has received rela-
tively little attention with respect to Alzheimer’s disease.
Among the various groups of thalamic nuclei, the limbic
thalamus stands out by virtue of its importance for cogni-
tion (Vogt and Gabriel, 1993; Aggleton and Brown, 1999).
Within this group, the anterior thalamic nuclei appear to
show the clearest structural changes with normal ageing
(Fama and Sullivan, 2015). In addition, anterior thalamic
dysfunctions are a core, contributing feature of diencephalic
amnesia, which is characterized by a loss of episodic
memory (Aggleton and Brown, 1999; Harding et al.,
2000; Van der Werf et al., 2003; Carlesimo et al., 2011).
Consequently, abnormalities in these nuclei have the poten-
tial to cause profound changes in cognition. The anterior
thalamic nuclei also stand out as, along with the laterodor-
sal thalamic nucleus, they have dense, reciprocal connec-
tions with both the hippocampal formation and
retrosplenial cortex (Amaral and Cowan, 1980; Aggleton
et al., 1986; Vogt et al., 1987; Xiao and Barbas, 2002a,b).
Furthermore, animal studies show how both anterior thal-
amic–hippocampal and anterior thalamic–retrosplenial
interconnections support aspects of episodic memory
(Sutherland and Hoesing, 1993; Parker and Gaffan, 1997;
Warburton et al., 2001; Henry et al., 2004).
Taken together, clinical and behavioural ﬁndings indi-
cate that interactions along Papez circuit (Fig. 1A), which
involve the hippocampus, fornix, mammillary bodies, an-
terior thalamic nuclei, and posterior cingulate region, are
critical for episodic memory (Delay and Brion, 1969;
Aggleton and Brown, 1999; Tsivilis et al., 2008;
Carlesimo et al., 2011). Consequently, this limbic net-
work could be of especial relevance when considering
the diagnosis and potential treatment of Alzheimer’s
disease.
The present review examines how thalamic changes
might contribute to Alzheimer’s disease symptomology.
The least contentious proposal is that medial temporal
lobe neuropathologies instigate dysfunctions across an
interconnected network of medial temporal, thalamic, and
parietal sites, thereby providing a more complete explan-
ation of the ways in which Alzheimer’s disease and its pro-
dromal stages affect memory. A more radical model is that
thalamic neuropathologies occur at the same time, or even
before, those in the medial temporal lobe. Consequently,
thalamic dysfunctions may contribute or even be respon-
sible for some of the earliest cognitive symptoms of mild
cognitive impairment (MCI) and Alzheimer’s disease. In
comparing these scenarios we will consider whether
medial temporal lobe pathology is sufﬁcient to explain
memory loss in Alzheimer’s disease or whether thalamic
pathology is a necessary feature.
Reﬂecting these various goals, the review ﬁrst considers
post-mortem evidence, as this provides the necessary ana-
tomical resolution to distinguish individual thalamic nuclei.
Next, non-invasive imaging ﬁndings from Alzheimer’s dis-
ease and its prodromal forms are described, including
ﬁndings from presymptomatic, at-risk patients.
Complementary evidence from animal models of dementia
is then described, which offers a way to isolate early disease
processes. Finally, evidence is provided from experimental
interventions that point to the importance of anterior thal-




In their landmark paper, Braak and Braak (1991a)
described the chronological staging of neuropathological
changes in Alzheimer’s disease. Their focus was on extra-
cellular amyloid (e.g. plaques) and intraneuronal neuroﬁb-
rillary changes (e.g. tau tangles and neuropil threads).
While amyloid deposition was variable, the pattern of
neuroﬁbrillary changes provided a more consistent se-
quence, beginning in the entorhinal region (Stages I–II).
Although Braak and Braak (1991a) emphasized the in-
volvement of the hippocampus (Stages III–IV) they exam-
ined many other areas. Of these other areas, the
anterodorsal thalamic nucleus stood out by having
marked neuroﬁbrillary changes at the same time as the
hippocampus (Stages III–IV), i.e. prior to many other sites
(Braak and Braak, 1991a).
A second report just considered the thalamus in post-
mortem Alzheimer’s disease brains (Braak and Braak,
1991b). While patches of amyloid were present across nu-
merous thalamic nuclei, neuroﬁbrillary changes were far
more restricted (Fig. 2). Many nuclei appeared largely un-
affected or showed only mild neuroﬁbrillary changes, even
in cases of severe Alzheimer’s disease (Braak and Braak,
1991b). Nevertheless, some thalamic nuclei (anterodorsal,
anteroventral, laterodorsal, central medial, parataenial, and
reticular nuclei) displayed conspicuous neuroﬁbrillary de-
posits (Fig. 2). These nuclei contrasted with the adjacent
medial dorsal nucleus, which appeared unaffected in their
study. As noted above, the anterodorsal nucleus was most
affected, being ‘infested’ with neuroﬁbrillary tangles (Braak
and Braak, 1991b; see also Xuereb et al., 1991). Dense
neuroﬁbrillary changes were also found between the ante-
roventral nucleus and the ependymal lining of the third
ventricle. The patterns of neuropathology in the laterodor-
sal nucleus closely mirrored those in the anteroventral nu-
cleus. By the later stages (V and VI), neuroﬁbrillary changes
were also prominent in nucleus reuniens and the reticular
thalamic nucleus, but these nuclei lacked amyloid patches
(Braak and Braak, 1991b). This distribution of tau path-
ology in the later stages of Alzheimer’s disease, i.e. focused
in the anterodorsal, laterodorsal, and paraventricular nuclei
of the limbic thalamus, has since been conﬁrmed (Ru¨b et
al., 2015).
This pattern of thalamic neuroﬁbrillary change is striking
as it preferentially maps onto those nuclei with reciprocal
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hippocampal connections (Fig. 1B). Hippocampal inputs
predominantly reach the thalamus via the fornix
(Aggleton, 2012), a tract that atrophies in Alzheimer’s dis-
ease and its prodromal stages (Hooper and Vogel, 1976;
Metzler-Baddeley et al., 2012; Nowrangi and Rosenberg,
2015). The source of these hippocampal–fornix–thalamic
inputs is the subiculum (Aggleton et al., 1986), a region
that shows pronounced cell loss and neuroﬁbrillary tangle
formation in Alzheimer’s disease (Hyman et al., 1990). The
result is a disconnection of the hippocampal formation in
Alzheimer’s disease, which presumably includes its projec-
tions to the anterior thalamic nuclei. Such disconnections
are likely to disrupt episodic memory (Tsivilis et al., 2008).
This conventional description of Alzheimer’s disease still
assumes that thalamic dysfunctions are a secondary re-
sponse to medial temporal lobe pathologies, a chronology
that may underestimate the extent to which thalamic dys-
function might initiate cognitive loss. This same standard
view overlooks the potential importance of the direct pro-
jections from the limbic thalamus to the hippocampal for-
mation (Amaral and Cowan, 1980; DeVito, 1980), as well
as the many indirect projections via the cingulate cortices
(Vann et al., 2009). Included among these thalamic
efferents to the hippocampus are those from nucleus
reuniens, a nucleus of growing interest as its reciprocal
hippocampal–prefrontal links appear to support learning
(Prasad and Chudasama, 2013; Xu and Su¨dhof, 2013).
Finally, more recent post-mortem studies indicate that
anterior thalamic pathology is present in other tau and
TAR DNA binding protein forms of dementia
(Hornberger et al., 2012; Tan et al., 2014). Anterior thal-
amic atrophy was observed in both the semantic variant of
primary progressive aphasia (semantic dementia) and the
behavioural variant of frontotemporal dementia, though
surprisingly, signiﬁcant volume reductions were not seen
in the Alzheimer’s disease cases in that study (Hornberger
et al., 2012) compared to age-matched controls.
Nevertheless, the extent of overall disruption to Papez cir-
cuit was seen as a predictor of the status of episodic
memory in these dementias (Hornberger et al., 2012; Tan
et al., 2014), which can mimic the episodic memory deﬁcits




Structural MRI provides insights into the status of the thal-
amus during the progression of Alzheimer’s disease. Such
imaging studies are, however, problematic as the thalamus
is composed of multiple nuclei, many of which cannot be
safely distinguished with MRI. Should Alzheimer’s disease
Figure 2 Post-mortem pathology in the anterior thalamus in patients with Alzheimer’s disease. The coronal images are taken with
permission from Braak and Braak (1991b). (A) Conspicuous patches of amyloid deposition in the anteroventral thalamic nucleus. (B) Presence of
neurofibrillary changes adjacent to the anteroventral thalamic nucleus. (C) Dense deposition of neurofibrillary tangles in the anterodorsal thalamic
nucleus. Av = anteroventral thalamic nucleus; Ad = anterodorsal thalamic nucleus; Pt = parataenial nucleus; SM = stria medullaris; Va = ventral
anterior nucleus.
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or its prodromal stages principally affect a small subset of
thalamic nuclei, as post-mortem studies indicate, misleading
null results are likely to occur. Furthermore, volume
changes may best reﬂect late stages in the progression of
neural dysfunction in Alzheimer’s disease, adding to the
insensitivity of the approach. Considering these limitations,
it is remarkable that thalamic changes are often described
in structural MRI studies.
Given the goals of this review, priority is given to studies
of MCI and its conversion to Alzheimer’s disease.
Reductions of thalamic volume are typically observed in
cases of amnestic MCI (Che´telat et al., 2005; Sorg et al.,
2007; Pedro et al., 2012; Yi et al., 2015). A stepwise de-
cline in thalamic status going from controls, to amnestic
MCI, to Alzheimer’s disease cases was also reported in an
analysis of thalamic tissue texture (de Oliveira et al., 2010).
Likewise, MRI-based measurements show that overall thal-
amic volume correlates with cognitive status in MCI (Pedro
et al., 2012; Yi et al., 2015). Furthermore, reduced thal-
amic volume is found in Alzheimer’s disease cases when
compared to other non-dementing individuals who reported
memory lapses (de Jong et al., 2008), with thalamic volume
again correlating with the decline in global cognitive per-
formance. Although one study found that thalamic atrophy
in MCI was not speciﬁcally associated with the risk of con-
version to Alzheimer’s disease (Yi et al., 2015), this null
result is confounded by its grouping together of diverse
thalamic nuclei.
It is evident that future studies need to target speciﬁc
groups or, ideally, individual thalamic nuclei. One such
study looked for MRI hyperdensities in the rostral thal-
amus (Swartz and Black, 2006), focusing on the anterior
thalamic nuclei. Thalamic abnormalities occurred at raised
frequencies in a variety of dementias, as well as in cases
who were cognitively impaired but had no current diagno-
sis of dementia. Anterior medial thalamic hyperdensities
were particularly associated with sudden onset or sudden
decline in cognitive abilities (Swartz and Black, 2006).
Another analysis focussed on the structure and connectivity
of ‘non-speciﬁc’ thalamic nuclei in Alzheimer’s disease
(Zarei et al., 2010). Shape analysis revealed signiﬁcant at-
rophy in the medial thalamus, with apparent connectivity
changes in the anterodorsal thalamus as well as atrophy of
the internal medullary lamina (Zarei et al., 2010). These
changes are informative as it is within the medial thalamus
that the mediodorsal nucleus, nucleus reuniens, and the
anterior thalamic nuclei are found, sites that are presumed
to support prefrontal cortex function via their dense recip-
rocal cortical connections (Ray and Price, 1993; Xiao and
Barbas, 2002a,b; Cross et al., 2012; Prasad and
Chudasama, 2013; Wright et al., 2013). These pathologies
within the medial thalamic region may also help to explain
why some prodromal cases predominantly display deﬁcits
in executive function (Reinvang et al., 2012), deﬁcits that
are assumed to arise from prefrontal dysfunctions. In add-
ition, some amnestic MCI patients show lesions in the an-
terior thalamic radiations associated with apathy (Torso
et al., 2015). Such lesions would potentially disconnect
the anterior thalamic nuclei, midline thalamic nuclei, and
mediodorsal thalamic nucleus from the prefrontal cortex,
presumably contributing to their symptoms.
A further imaging approach has used resting-state func-
tional MRI activity to look for changes in inter-area con-
nectivity. Such studies of MCI patients report evidence of
reduced connectivity between the thalamus and multiple
cortical areas (Wang et al., 2012; Cai et al., 2015), includ-
ing components of the ‘default mode network’ (see below).
At the same time, signals of increased connectivity between
the left and right thalamus have been interpreted as com-
pensatory mechanisms (Wang et al., 2012; Cai et al.,
2015). Additional comparisons between early and late
stage amnestic MCI patients (Cai et al., 2015) point to
progressive, disruptive effects on various thalamic net-
works, including thalamo–hippocampal, thalamo–temporal,




The realization that Alzheimer’s disease has an extended
prodromal phase, possibly lasting decades (Jack et al.,
2013), makes it desirable to examine the status of the thal-
amus in healthy people at heightened genetic risk of
Alzheimer’s disease. At ﬁrst glance, this logic might be
questioned because the experiments look for thalamic
abnormalities when there is no corresponding disruption
of memory, as the cases are ‘presymptomatic’. In fact, the
emerging view is that memory loss in these ‘presympto-
matic’ stages is often obscured by ones ‘cognitive reserve’
(Amieva et al., 2014). Furthermore, ‘presymptomatic’ pa-
tients could have more subtle memory deﬁcits that do not
reach the threshold for a full-blown memory problem in
standard neuropsychological tests. Damage to sites such
as the anterior thalamus could, therefore, act as a tipping
point for when symptoms of Alzheimer’s disease ﬁrst
appear (Swartz and Black, 2006).
One valuable approach comes from the study of preseni-
lin 1 (PSEN) mutation carriers. Studies using PET-based
markers have reported increased amyloid load in the thal-
amus in presymptomatic presenilin 1 cases (Knight et al.,
2010). Other imaging studies of presenilin 1 have reported
that the earliest sites of amyloid deposition are the thal-
amus and striatum (Ryan et al., 2013). Reduced thalamic
volume (but not hippocampal volume) was also noted in
these same presymptomatic cases, along with evidence of
thalamic white matter changes (Ryan et al., 2013). Other
studies of presymptomatic carriers of familiar Alzheimer’s
disease mutations have also reported atrophy in the thal-
amus, as well as the striatum, while temporal lobe changes
appear less consistent (Lee et al., 2013). One potential issue
is that these ﬁndings have not yet been conﬁrmed by post-
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mortem examination. Another concern is that apparently
excessive amyloid deposition can be observed among cog-
nitively normal elderly subjects (Aizenstein et al., 2008).
A related source of evidence comes from comparing
healthy carriers of the apolipoprotein (APOE) e4 allele,
which increases the risk of Alzheimer’s disease, with
APOE e2 allele carriers, which protect against
Alzheimer’s disease (Corder et al., 1993). Carriers of the
APOE e4 allele show disruptions of the default mode net-
work, which involves the posterior cingulate region
(Pihlajama¨ki et al., 2010; Patel et al., 2013). The implica-
tion is that such disruptions render people more susceptible
to the advance of Alzheimer’s disease. Meanwhile,
increased functional connectivity involving the thalamus
has been reported in APOE e2 carriers (Patel et al.,
2013), which confers protection from Alzheimer’s disease.
Further support for this network explanation comes from
evidence that APOE e2 carriers have increased white
matter integrity in a number of sites, including the anterior
thalamic radiations and the right thalamus, as well as the
posterior cingulum bundle (Chiang et al., 2012), which in-
nervates the posterior cingulate region and the anterior
thalamic nuclei (Mufson and Pandya, 1984). Meanwhile,
changes in parahippocampal white matter were not found
in the same study (Chiang et al., 2012).
Volumetric analyses of APOE e4 carriers (increased risk
of Alzheimer’s disease) have focused on the medial tem-
poral lobes, where reduced hippocampal volumes are some-
times, but not always, found (Adamson et al., 2010;
O’Dwyer et al., 2012; Li et al., 2014). While thalamic
volume need not appear to alter in these at-risk cases
(O’Dwyer et al., 2012), these null results are constrained
by treating the thalamus as a single structure. Finally, the
hippocampus has been used as a ‘seed’ for functional con-
nectivity analyses of Papez circuit in APOE e4 carriers (Li
et al., 2014). In comparisons with non-carriers, reduced
hippocampal functional connectivity was found in a
number of sites, including the thalamus, while hippocampal
functional connectivity correlated with episodic memory
performance (Li et al., 2014). These ﬁndings can readily
be interpreted as a disruption of Papez circuit, with conse-




Within the context of Alzheimer’s disease symptomology,
the potential importance of interactions between the anter-
ior thalamic nuclei and retrosplenial cortex has already
been stressed (Fig. 1). The retrosplenial cortex (areas 29
and 30) comprises part of the posterior cingulate region,
which also contains areas 23 and 31. The anterior thalamic
nuclei have a particularly close afﬁnity with the posterior
cingulate region, which is most pronounced for
retrosplenial cortex (Vann et al., 2009). In both primate
and rodent brains there are dense, reciprocal connections
linking retrosplenial cortex with the anterior thalamic
nuclei and the laterodorsal nucleus (Vogt et al., 1987;
Morris et al., 1999; Aggleton et al., 2014). Reﬂecting this
close relationship, disconnection studies with rats show that
the anterior thalamic nuclei and retrosplenial cortex func-
tion in an interdependent manner for spatial learning
(Sutherland and Hoesing, 1993; Dumont et al., 2010).
Although there is a need to study other forms of learning,
spatial memory has often proved to be a valuable marker
for hippocampal involvement in episodic-like memory in
animals (Aggleton and Pearce, 2001).
The strongest indication of the potential importance of
retrosplenial cortex dysfunction in Alzheimer’s disease
comes from PET, as well as functional MRI studies,
which have repeatedly shown posterior cingulate hypoac-
tivity in MCI and Alzheimer’s disease (Minoshima et al.,
1997; Nestor et al., 2003a, b; Buckner et al., 2005;
Drzezga et al., 2011). Of particular signiﬁcance was the
realization that this hypoactivity, typically centred in the
retrosplenial cortex, is often the ﬁrst metabolic change to
be detected in MCI and Alzheimer’s disease, i.e. prior to
changes in the medial temporal lobe (Minoshima et al.,
1997; Nestor et al., 2003b). Intriguingly, comparisons of
metabolic activity between cases with MCI and those with
mild Alzheimer’s disease revealed that the latter
(Alzheimer’s disease cases) displayed additional hypometa-
bolism in the amgydala, temporoparietal and frontal asso-
ciation cortices. Consequently, this comparison reveals a
core network of hypometabolic limbic structures (hippo-
campal, medial thalamus, mammillary bodies, posterior
cingulate, including retrosplenial cortex) particularly asso-
ciated with MCI (Nestor et al., 2003a).
Subsequent structural MRI research has revealed volume
changes in the posterior cingulate region in amnestic MCI
and the early stages of Alzheimer’s disease (Scahill et al.,
2002; Che´telat et al., 2005; Frisoni et al., 2009; Pengas
et al., 2010), though not in behavioural variant frontotem-
poral dementia (Tan et al., 2013). The descriptions of MCI
cases show that posterior cingulate (including retrosplenial
cortex) atrophy is present from the earliest clinical stages of
Alzheimer’s disease, indicating that this region is as vulner-
able as the hippocampus (Frisoni et al., 2009; Pengas et al.,
2010). Furthermore, the volume of the posterior cingulate
region, as well as hippocampal volume, helps to predict the
conversion of MCI to Alzheimer’s disease (Che´telat et al.,
2005). The implication is that pathological changes asso-
ciated with retrosplenial cortex hypoactivity may occur
prior to those in the medial temporal lobe, that is, in a
cortical region with especial afﬁnity for the anterior thal-
amic nuclei.
The posterior cingulate region, including the retrosplenial
cortex, is a key component of the default mode network
(Greicius et al., 2003; Raichle, 2015). This network, which
shows greater activity during resting states than during
many cognitive tasks, involves medial prefrontal, parietal
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and medial temporal lobe areas (Raichle, 2015). Two thal-
amic sites strongly interconnected with this network are the
anterior nuclei and the dorsomedial nucleus. It is, therefore,
notable that a lesion in the left anterior thalamus disrupted
the posterior cingulate portion of the default mode net-
work, ipsilateral to the pathology (Jones et al., 2011).
The relevance of this ﬁnding comes from the discovery
that the default mode network is affected in amnestic
MCI and Alzheimer’s disease, with changes in the network
predicting conversion of MCI to Alzheimer’s disease
(Greicius et al., 2003; Sorg et al., 2007; Petrella et al.,
2011; Wang et al., 2013). These default mode network
changes in MCI and Alzheimer’s disease consistently in-
volve the posterior cingulate/retrosplenial areas (Greicius
et al., 2003; Sorg et al., 2007) i.e. those sites most closely
linked with the anterior thalamic nuclei. Indeed, studies of
MCI patients reveal that the connectivity changes in this
disorder involve the thalamus (Wang et al., 2013; Zhou
et al., 2013). Furthermore, default mode correlations with
memory performance in MCI have been found for the thal-
amus, as well as the hippocampus (Wang et al., 2013).
Thus, although research on the default mode network
and its disruption in Alzheimer’s disease has concentrated
on cortical mechanisms, there are good grounds to suppose
that thalamic dysfunctions contribute to these changes.
Studies with animals have more precisely examined an-
terior thalamic–retrosplenial cortex relationships, i.e. tar-
geted this link within Papez circuit. In a series of rodent
studies, anterior thalamic lesions consistently produced
chronic dysfunctions in retrosplenial cortex (Aggleton and
Nelson, 2015). These dysfunctions included disrupted gene
transcription, e.g. a loss of immediate-early gene expres-
sion, as well as reduced metabolic activity and a loss of
some forms of neuronal plasticity (Van Groen et al.,
1993; Jenkins et al., 2004; Poirier et al., 2008; Garden
et al., 2009; Dumont et al., 2012; Mendez-Lopez et al.,
2013). Consequently, there are good grounds to believe
that the integrity of the anterior thalamic nuclei is vital
for retrosplenial cortex activity and function. The extent
of this structural interdependence can be widened further
as anterior thalamic lesions also disrupt markers of neur-
onal plasticity in the hippocampus (Jenkins et al., 2002;
Dumont et al., 2012). The implication is that these limbic
structures function in a network that depends on the integ-
rity of all components.
Clinical studies of anterograde amnesia reveal that both
the retrosplenial cortex and anterior thalamic nuclei are
vital for episodic memory (Aggleton and Brown, 1999;
Harding et al., 2000; Maguire, 2001; Vann et al., 2009;
Carlesimo et al., 2011). Such ﬁndings underline the poten-
tial impact of disturbances to anterior thalamic–posterior
cingulate interactions during the progression of Alzheimer’s
disease. However, very few studies have explored how ret-
rosplenial-thalamic changes might affect clinical presenta-
tion. In a recent exception, patients with Alzheimer’s
disease were shown to be particularly impaired when
asked to change from allocentric to egocentric spatial
orientations (Tu et al., 2015), a difﬁculty that correlated
strongly with retrosplenial/posterior cingulate atrophy in
the same patients. This result closely matches animal ﬁnd-
ings, which indicate that spatial orientation changes require
the concerted actions of the hippocampus, posterior cingu-
late cortex, and anterior thalamus, with the retrosplenial
cortex being the hub for these interactions (Byrne et al.,
2007; Vann et al., 2009; Nelson et al., 2015). This com-
parative approach provides a promising avenue for future
research on thalamic-retrosplenial interactions.
Unfortunately, one class of evidence largely lacking at
present concerns the impact of retrosplenial cortex dysfunc-
tion upon anterior thalamic activity, i.e. whether cortical
pathologies automatically lead to thalamic abnormalities.
It is, however, known that retrosplenial lesions in rats
result in both gliosis and cell loss in the anterior thalamic
nuclei, neuropathologies that are most evident in the medial
part of the anteroventral thalamic nucleus (Neave et al.,
1994). Likewise, hippocampal lesions in rats reduce imme-
diate-early gene activity in the anterior thalamic nuclei and
retrosplenial cortices (Jenkins et al., 2006; Albasser et al.,
2007). Another intriguing piece of evidence for the inter-
dependency of these sites comes from a patient with retro-
splenial damage associated with anterograde amnesia
(Heilman et al., 1990). Measurements of metabolic activity
(PET) revealed thalamic hypoactivity, but no apparent
medial temporal lobe changes (Heilman et al., 1990).
From a neurodegenerative perspective, patients with
C9orf72 mutations might be of particular relevance when
investigating structural relationships in Alzheimer’s disease.
Such C9orf72 patients belong to the frontotemporal de-
mentia–amyotrophic lateral sclerosis spectrum, which usu-
ally affects more prefrontal, motor and temporal cortices.
However, C9orf72 patients present with signiﬁcant parietal
(including retrosplenial cortex) and thalamic atrophy
(Mahoney et al., 2012; Whitwell et al., 2012; Irish et al.,
2013). Interestingly, these changes have been associated
with more signiﬁcant episodic memory problems, despite
the patients having relatively intact medial temporal lobes
(Irish et al., 2013). Thus, future contrasts of C9orf72 and
Alzheimer’s disease might be of particular interest in deli-
neating the functions of the thalamic-retrosplenial axis and
their potential role in Alzheimer’s disease symptomology.
These contrasts should be corroborated by more formal
experiments to detail anterior thalamic–retrosplenial inter-
actions in animal models of Alzheimer’s disease.
Animal models
Genetically modiﬁed animals offer an alternative means to
study the progression of particular pathological features in
Alzheimer’s disease. These models often involve the abnor-
mal production of amyloid plaques, tau neuroﬁbrils, or
both. One of the most important reasons for using
animal models is to provide the anatomical speciﬁcity
that would otherwise be unobtainable in humans.
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Unfortunately, this opportunity has often been wasted
when it comes to the thalamus. Instead, there has been
considerable focus on the status of the hippocampal forma-
tion in these models. Consequently, current ﬁndings con-
cerning the thalamus remain sketchy, despite the large
number of animal studies that have adopted this general
approach.
One of the ﬁrst mouse models to be examined was the
Tg2576 APP (swe) strain, which shows excessive deposition
of amyloid-b (Hsiao et al., 1996). Studies of this mouse
have repeatedly focused on the hippocampal formation,
but one set of analyses principally examined retrosplenial
cortex (Poirier et al., 2011). That study reported clear
changes in markers for neuronal activity and metabolism
in the retrosplenial cortex long before evidence of plaque
formation in the brain (Poirier et al., 2011). Related ana-
lyses showed that subsequent amyloid-b deposition in the
anterior thalamic nuclei was closely associated with amyl-
oid-b deposition in the retrosplenial cortex (Poirier et al.,
2011). Other evidence comes from a double mutant strain
with excessive amyloid-b deposition (APPswe/PS1dE9), in
which seizures become apparent at the time of plaque for-
mation (Gurevicius et al., 2013). Changes in both thalamic
and cortical excitability (local ﬁeld potentials and EEG)
were present (Gurevicius et al., 2013).
In a third mouse line (TgaPParc), diffuse amyloid-b de-
position ﬁrst appears in the subiculum, with some animals
also showing early changes in retrosplenial cortex
(Ro¨nnba¨ck et al., 2012). Amyloid changes then occur in
the mammillary bodies and thalamus, followed later by
the dentate gyrus and hippocampal CA ﬁelds. These results
were interpreted as a pattern of spread along Papez circuit,
starting in the subiculum (Ro¨nnba¨ck et al., 2012).
Unfortunately, the precise thalamic nuclei with excessive
amyloid deposition were not speciﬁed (Ro¨nnba¨ck et al.,
2012). In a follow-up study of this same genetic model,
subiculum lesions reduced amyloid levels in CA1 and the
retrosplenial cortex (George et al., 2014). While these re-
sults are consistent with a pattern of spread emanating
from the subiculum, that study (George et al., 2014) did
not include data for the anterior thalamus.
In a mouse model that combines both amyloid-b and tau
pathology, signiﬁcant neuronal loss occurs in the subiculum
and hippocampus (Wilcock et al., 2008), so mimicking
additional features of human Alzheimer’s disease.
Immunohistochemical analyses revealed particularly dense
amyloid-b staining in the subiculum and thalamus in this
same mouse model. In addition, hyperphosphorylation of
tau occurred in the same subiculum and thalamic locations
(Wilcock et al., 2008). Unfortunately, the report did not
specify the precise thalamic location of these pathological
changes (Wilcock et al., 2008).
It is evident that future studies of such models should
take full advantage of the anatomical precision made pos-
sible by animal studies. Advances include the visualization
of thalamic amyloid-b plaques using high-ﬁeld scanning
methods (Faber et al., 2007). A key goal will be to provide
longitudinal analyses of individual thalamic nuclei, relating
any cognitive changes to those seen in temporal, parietal,
and frontal lobe areas. While it is inevitable that the focus
will be on behavioural measures of memory loss, research
using broader test batteries have revealed additional deﬁcits
in attention and response control in transgenic models of
Alzheimer’s disease (Romberg et al., 2013).
Clinical and therapeutic
implications
The present review has amassed evidence that the limbic
thalamus forms a critical hub for episodic memory and
spatial orientation and, therefore, could impact on the
symptomology in Alzheimer’s disease and its prodromal
phases. As outlined above, the consequences of thalamic
dysfunction in individual thalamic nuclei are barely recog-
nized in accounts of Alzheimer’s disease, a situation that
needs correcting. More speciﬁcally, clinicians should not
only take account of hippocampal atrophy on clinical
scans but also consider concurrent anterior thalamic and
retrosplenial changes. Previous evidence (e.g. Hornberger
et al., 2012) has shown that thalamic changes can have
an additional impact on episodic memory, even when the
hippocampi are grossly affected by neurodegenerative path-
ology. One priority would be to develop speciﬁc cognitive
measures that tap into anterior thalamic dysfunction. Such
tests might then be used as outcome measures in thera-
peutic disease intervention trials.
Some guidance for these goals comes from clinical and
behavioural studies that have provided new insights into
how anterior thalamic activity may contribute to memory.
Recent in vivo intra-thalamic recordings in volunteer pa-
tients suffering from epilepsy (Sweeney-Reed et al., 2014,
2015) have revealed correlates between anterior thalamic
activity and learning. In particular, neocortical–anterior
thalamic nuclei synchrony (theta-gamma cross-frequency
coupling) predicted subsequent memory performance
(Sweeney-Reed et al., 2014). Successful memory encoding
was also related to theta phase alignment in the anterior
thalamic nuclei (Sweeney-Reed et al., 2015). Meanwhile,
recording studies in rats have uncovered neurons in the
anterior thalamic nuclei that show spatial ﬁring reﬂecting
different aspects of location and navigation, indicative of
high-resolution information processing (Jankowski et al.,
2015).
At the same time, both recent clinical and behavioural
studies are starting to reveal that the anterior thalamic
nuclei have additional roles, e.g. in regulating attention. It
is presumed that these roles partly reﬂect their dense, recip-
rocal connections with prefrontal and parietal cortices. An
analysis of stroke patients found that pathologies involving
the anterior and ventrolateral thalamus disrupt the inter-
play between working memory and attention (de Bourbon-
Teles et al., 2014). A complementary behavioural study
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highlighted a role for the rat anterior thalamic nuclei in
guiding attention to task-relevant stimuli (Wright et al.,
2015). For these reasons, it would be informative to look
for changes in both episodic memory and executive func-
tion, including attention based on learnt contingencies,
when using cognitive assays of Alzheimer’s disease and its
prodromal conditions.
Such analyses build on considerable evidence that both
Alzheimer’s disease and MCI are associated with losses in
some forms of attention (Perry and Hodges, 1999, 2003;
Belleville et al., 2007). Tests of divided attention and set-
shifting are disrupted in early Alzheimer’s disease (Perry
and Hodges, 1999; Perry et al., 2000), with related studies
indicating that MCI impairs top-down attentional control,
while sparing attentional dwell time (Perry and Hodges,
2003; Belleville et al., 2007). At the same time, functional
MRI evidence from attentional tasks points to changes in
networks linked with prefrontal cortex in cases of MCI and
Alzheimer’s disease (Dannhauser et al., 2005; Hao et al.,
2005). Tests of set-formation and set-shifting are of par-
ticular interest as they are disrupted in early Alzheimer’s
disease (Perry et al., 2000) and have recently been linked to
anterior thalamic function (de Bourbon-Teles et al., 2014;
Wright et al., 2015). While set-shifting is closely tied to
prefrontal and parietal functions (Dias et al., 1996;
Rushworth et al., 2001), the hippocampus appears far
less critical for this function (Milner et al., 1968; Owen
et al., 1991). This pattern of results points to the value
of examining whether thalamic neuropathology is related
to the attentional changes seen in MCI and Alzheimer’s
disease, with the appreciation that there are different sub-
types of each disorder, reﬂecting different patterns of
memory loss (Petersen, 2004). A further consideration is
the way in which attentional deﬁcits might impact on
memory.
It is important to stress that the signiﬁcance of the anter-
ior thalamic nuclei for cognition arises from their being
both upstream and downstream of the hippocampus
(Aggleton and Brown, 1999; Vann, 2013; Fig. 1). One po-
tential application, which reﬂects their upstream status,
arises from the way that gradual neurodegenerative pro-
cesses may leave viable, residual medial temporal lobe
tissue for a long proportion of time during the disease pro-
cess. This situation creates the possibility that thalamic
stimulation might maintain or even boost memory and at-
tention. Indeed, it is known that in both rats and mice, high
frequency electrical stimulation of the anterior thalamic
nuclei can increase hippocampal neurogenesis (Toda et
al., 2008; Encinas et al., 2011; Hamani et al., 2011;
Zhang et al., 2015). This same treatment can help to im-
prove spatial learning in rats (Encinas et al., 2011; Zhang
et al., 2015). In a further study, amyloid-b1-40 was ﬁrst
injected into the hippocampus of rats, followed by electrical
stimulation of the anterior thalamic nuclei (Chen et al.,
2014). This treatment improved spatial learning in these
compromised rats. One potential limitation with these
rodent stimulation studies is that the anterior thalamic
nuclei remain intact, while in cases of MCI or
Alzheimer’s disease the staging of the neuropathological
changes is such that thalamic dysfunction could comprom-
ise the efﬁcacy of such an approach.
Even so, a related procedure has been attempted in
human volunteers. This approach involved chronic deep
brain stimulation in the region of the fornix in patients
with mild, probable Alzheimer’s disease (Laxton et al.,
2010; Smith et al., 2012). Patients received continuous
stimulation for 12 months. Imaging studies (functional
MRI and PET) showed that the stimulation activated the
default mode network and drove neural activity in the
hippocampus (Laxton et al., 2010). Increases in glucose
utilization were found in frontal, temporal, and parietal
networks that involved the thalamus (Smith et al., 2012).
The same procedure was associated with improved out-
comes for global cognition, memory, and quality of life
(Smith et al., 2012). The location of the fornix stimulating
electrodes is of particular relevance as they were placed in
the hypothalamus, close to the posterior commissural div-
ision of the fornix. This component of the fornix princi-
pally innervates the mammillary bodies (Poletti and
Creswell, 1977). If the deep brain stimulation activated
the fornix, as assumed (Laxton et al., 2010), it would not
only directly activate the mammillary bodies but would
also indirectly activate the anterior thalamic nuclei, via
the mammillothalamic tract (Vann and Aggleton, 2003;
Vann et al., 2007; Dillingham et al., 2015). The status of
the mammillothalamic tract has been strongly associated
with episodic memory function (Van der Werf et al.,
2003; Carlesimo et al., 2011; Danet et al., 2015).
Future investigations should increasingly consider the
interactions of tau and amyloid pathology across Papez
network. The rationale for such an approach is supported
by a recent study (Khan et al., 2014) showing that entorh-
inal dysfunction is better explained by the interaction of tau
and amyloid pathology than either separately. The advent
of tau-ligand PET imaging has further corroborated this
picture, showing that pathological interactions of tau and
amyloid can better explain disease progression and symp-
tomology in Alzheimer’s disease than either individual
pathology (Khan et al., 2014). Khan and colleagues
(2014) also showed that tau-amyloid interaction not only
affected the entorhinal cortex but also inﬂuenced its con-
nectivity to the parietal cortex and, thus potentially, pos-
terior cingulate and retrosplenial areas. A similar scenario
can be imagined for the thalamus, in which combined tau–
amyloid interactions explain the emergence of dysfunctions
in this region better than simple correlations with amyloid
or tau per se.
It remains the case, however, that current analyses typic-
ally take a hippocampal-centred view, with medial temporal
lobe changes seen to instigate mnemonic dysfunctions. While
this view might prove to be correct, it is surely necessary to
test alternative models of the neuropathological progression
in Alzheimer’s disease. In fact, the breadth and depth of
evidence supports a network model (Acosta-Cabronero and
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Nestor, 2014), which also more accurately reﬂects what we
now know about the normal anatomical substrates for epi-
sodic memory (Aggleton and Brown, 1999). Such distributed
models also highlight the importance of determining white
matter microstructure in those tracts linking key sites within
the network, namely the fornix and cingulum bundle (Fig. 1)
(Acosta-Cabronero and Nestor, 2014). This broader orien-
tation also provides a basis from which to compare those
dementias with different pathologies, yet are able to afﬂict
memory in apparently similar ways (Frisch et al., 2013). The
same body of evidence points to the real possibility that a
break down in anterior thalamic– retrosplenial interactions
might be the starting point for the characteristic, early loss
of episodic memory in prodromal Alzheimer’s disease, with
thalamic dysfunctions occurring at the same time, or even
before, those in the hippocampus. A related view is that
thalamic pathology may provide a tipping point for when
medial temporal lobe dysfunctions become symptomatic.
This review challenges prevalent views about the genesis
of Alzheimer’s disease. Two principal issues are: (i) whether
hippocampal pathology is sufﬁcient to explain the loss of
episodic memory in MCI and Alzheimer’s disease; and (ii)
whether thalamic pathology is necessary for these cognitive
changes. While it is not yet possible to be conclusive on
either issue, there is considerable evidence that thalamic
dysfunctions in sites critical for episodic memory are an
early (presymptomatic) feature of the disorder. It is also
apparent that there are subtypes of Alzheimer’s disease
that differ in their relative extent of hippocampal pathology
(Whitwell, et al., 2012). Furthermore, it is striking that
cases of semantic dementia and Alzheimer’s disease can
appear to have comparable levels of medial temporal
hypoactivity, yet differ markedly in their episodic memory
status (Nestor et al., 2006). While the additional semantic
memory loss in semantic dementia was associated with an-
terior temporal cortex hypometabolism, the additional epi-
sodic memory loss in Alzheimer’s disease was associated
with dysfunctions in the diencephalic (mammillary bodies,
medial thalamus) and posterior cingulate (including retro-
splenial) network (Nestor et al., 2006). Meanwhile, studies
of diencephalic amnesia have repeatedly shown that overt
hippocampal pathology is not a necessary condition for
severe episodic memory loss. Taken together, there is a
strong case for a detailed, systematic approach to the con-
tributions of the limbic thalamus to the progression of
memory loss in MCI and Alzheimer’s disease, in which
an open mind is kept concerning the primacy of the
hippocampus.
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